Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Nycomed licenses TransMID from KS Biomedix in Europe

Sep. 20, 2002

Edrecolomab effective against bone marrow metastases of breast cancer

Sep. 17, 2002

INDs filed for M-Vax and O-Vax

Sep. 16, 2002

Melacine rights return to Corixa

Sep. 13, 2002

Zadaxin enters phase II combination trial in malignant melanoma

Sep. 12, 2002

PI-88 enters phase I in combination with Taxotere

Sep. 10, 2002

Kirin initiates phase II Mylovenge trials in Japan

Sep. 9, 2002

Enrollment completed in phase II study of EGF cancer vaccine

Sep. 6, 2002

Pfizer and Abgenix disclose monoclonal antibodies that specifically bind to IGF-IR

Sep. 3, 2002

Novuspharma and Micromet to codevelop MT-201 for cancer

Sep. 3, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...